Literature DB >> 2393300

Inhibition of cathepsin B and papain by peptidyl alpha-keto esters, alpha-keto amides, alpha-diketones, and alpha-keto acids.

L Y Hu1, R H Abeles.   

Abstract

A series of peptidyl alpha-keto esters, alpha-keto amides, alpha-keto acids, and alpha-diketones were synthesized which reversibly inhibit papain and cathepsin B. Methyl 3-(N-benzyloxycarbonyl-L-phenylalanyl)amino-2-oxopropionate (a dicarbonyl compound) inhibits papain with a Ki value of 1 microM, whereas the Ki of 3-(N-acetyl-L-phenylalanyl)aminopropanone (a monocarbonyl compound) is 1.5 mM (M. R. Bendall et al., 1979. Eur. J. Biochem. 79, 201-209). Both carbonyl groups are required for effective inhibition. Extension of these inhibitors by addition of P substituents (e.g., hexyl) does not affect the Ki for papain, but reduces Ki for cathepsin B 33-fold. For these two enzymes slow binding inhibition was observed with slow on rates (kappa on, 5.2 X 10(2) M-1 s-1 for papain, and 2.7 X 10(3) M- s-1 for cathepsin B). Addition of a P3 substituent (glycine) has no effect on Ki. We propose that the mechanism of inhibition involves the formation of a hemithioketal by addition of the active-site thiol to the carbonyl group of the inhibitor closer to the N-terminus. The hemithioketal intermediate is most likely stabilized by the electron withdrawing effect of the second carbonyl group.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393300     DOI: 10.1016/0003-9861(90)90443-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.

Authors:  B E Maryanoff; X Qiu; K P Padmanabhan; A Tulinsky; H R Almond; P Andrade-Gordon; M N Greco; J A Kauffman; K C Nicolaou; A Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

2.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Authors:  J S Stamler; D I Simon; J A Osborne; M E Mullins; O Jaraki; T Michel; D J Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Inhibitors of human heart chymase based on a peptide library.

Authors:  M Bastos; N J Maeji; R H Abeles
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

4.  A Diverse Library of Chiral Cyclopropane Scaffolds via Chemoenzymatic Assembly and Diversification of Cyclopropyl Ketones.

Authors:  Donggeon Nam; Viktoria Steck; Robert J Potenzino; Rudi Fasan
Journal:  J Am Chem Soc       Date:  2021-01-26       Impact factor: 15.419

Review 5.  Organic carbamates in drug design and medicinal chemistry.

Authors:  Arun K Ghosh; Margherita Brindisi
Journal:  J Med Chem       Date:  2015-01-07       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.